Osteoarthritis — an untreatable disease?
The DOI matches its Crossref record; 123 of the 124 references it cites were found in a registry or an index.
Abstract
Osteoarthritis is a painful and disabling disease that affects millions of patients. Its aetiology is largely unknown, but is most likely multi-factorial. Osteoarthritis poses a dilemma: it often begins attacking different joint tissues long before middle age, but cannot be diagnosed until it becomes symptomatic decades later, at which point structural alterations are already quite advanced. In this review, osteoarthritis is considered as a disease of the whole joint that may result from multiple pathophysiological mechanisms, one of which is the dysregulation of lipid homeostasis. No proven disease-modifying therapy exists for osteoarthritis and current treatment options for chronic osteoarthritic pain are insufficient, but new pharmacotherapeutic options are emerging.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a chronic disease characterized by degeneration of articular cartilage leading to pain and physical disability.”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [10]
In the citing paper
“Aging and trauma are risk factors for the development of osteoarthritis (OA)10”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [10]
Citations
Cites
1 retracted
Yagami, K., Uyama, Y., Yoshizawa, Y., Kakuta, S., Yamaguchi, A., & NAGUMO, M. (2004) · Bone · doi:10.1016/j.bone.2003.12.016 · Cited by 17 · cited 1×
“Interestingly, adipocytes share a common mesenchymal stem-cell precursor with osteoblasts and chondrocyte”
BackgroundRetractedCan the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734 · cited 1×
“COX1 is constitutively expressed in many cell types, whereas COX2 is induced at the site of inflammation, although it is also constitutively expressed in the kidney, for exampl”
BackgroundLeptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011742 · Cited by 2,048 · cited 1×
“It is recommended as a first-line oral analgesic for knee O”
BackgroundCharbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735 · cited 1×
“Besides its role in regulating caloric intake, leptin regulates bone mass and mineralization through a neuroendocrine pathway involving the sympathetic nervous syste”
BackgroundWarner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., Bonventre, J. V., & Woolf, C. J. (2001) · Nature · doi:10.1038/35068566 · Cited by 1,281
Research works printed but not linked: 6
- Harris, E. D. Jr. The Bone and Joint decade: a catalyst for progress. Arthritis Rheum 44, 1969–1970 (2004). · doi:10.1002/1529-0131(200109)44:9<1969::aid-art342>3.0.co;2-a
- Brandt, K. D., Smith, G. N. Jr & Simon, L. S. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum. 43, 1192–1203 (2000). · doi:10.1002/1529-0131(200006)43:6<1192::aid-anr2>3.0.co;2-l
- Bingham, C. et al. Clinically significant placebo improvement occurs by 6 months and is maintained through 24 months in a study of knee OA pain and function. Osteoarthr. Cartil. 12, S132 Abs. P323 (2004).
- Flechtenmacher, J. et al. Bradykinin-receptor-inhibition — a therapeutic option in osteoarthritis? Osteoarthr. Cartil. 12, S137 Abs. P332 (2004).
- Ding, C & Cicuttini, F. Licofelone (Merckle). IDrugs 6, 802–808 (2003).
- Schnitzer, T. J., Kivitz, A. J., Lipetz, S., Sanders, N. & Hee, A. A Phase II study of the efficacy and safety of AZD3582, a CINOD, in subjects with osteoarthritis of the knee. Eur. League Against Rheumatism 2004 Conference Abs OP0016 [online], < http://mcic3.textor.com/cgi-bin/mc/printabs.pl?APP=eular2004SCIE-abstract&TEMPLATE=&keyf=0094&showHide=show&client= > (2004)
Cited by
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
“In one mouse model, injection of UBX0101 selectively eliminated senescent cells and reduced proteoglycan loss, which alleviated the cartilage degradation and pain caused by OA.339 Fenofibrate, a PPARα agonist, clears SAβ-gal-positive chondrocytes by promoting apoptosis.595 Fisetin, a flavonoid drug, alleviates inflamm…”
BackgroundInfluentialJeon, O. H., Kim, C., Laberge, R.-M., Demaria, M., Rathod, S., Vasserot, A. P., Chung, J. W., Kim, D. H., Poon, Y., David, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4324 · Cited by 1,515
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Proteases involved in cartilage matrix degradation in osteoarthritis
Troeberg, L., & Nagase, H. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.06.020 · Cited by 579
Tang, S., Zhang, C., Oo, W. M., Fu, K., Risberg, M. A., Bierma-Zeinstra, S. M., Neogi, T., Atukorala, I., Malfait, A.-M., Ding, C., et al. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00594-6 · Cited by 476
“Once regarded as a simple ‘wear and tear’ or ‘degenerative’ joint disease, OA is now understood as a complex, multifactorial disorder affecting the entire joint, including the bone, cartilage, ligaments and muscles 2,3 (Fig.”
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
Intraarticular drug delivery in osteoarthritis☆
GERWIN, N., HOPS, C., & LUCKE, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.018 · Cited by 442
Krishnan, Y., & Grodzinsky, A. J. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.005 · Cited by 443
Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage
Rothenfluh, D. A., Bermudez, H., O’Neil, C. P., & Hubbell, J. A. (2008) · Nature Materials · doi:10.1038/nmat2116 · Cited by 388
“This approach provides a route to target an otherwise poorly accessible avascular tissue and may prove useful in drug and biomolecular therapy in diseases such as osteoarthriti”
BackgroundRahmati, M., Mobasheri, A., & Mozafari, M. (2016) · Bone · doi:10.1016/j.bone.2016.01.019 · Cited by 374
Senescent cells and osteoarthritis: a painful connection
Jeon, O. H., David, N., Campisi, J., & Elisseeff, J. H. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95147 · Cited by 356
“, hyaluronic acid) achieve short-term symptomatic pain relief and care of joint function (3).”
Cartilage-targeting drug delivery: can electrostatic interactions help?
Bajpayee, A. G., & Grodzinsky, A. J. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.210 · Cited by 325
Nanoparticles: Functionalization and Multifunctional Applications in Biomedical Sciences
Subbiah, R., Veerapandian, M., & S. Yun, K. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710794183024 · Cited by 327
“Rothenfluh et al reported on the development of a novel NPs based drug delivery system for intra tissue drug release in articular cartilage, which may prove useful in drug and biomolecular therapy in diseases such as osteoarthritis [118, 119].”
BackgroundSacitharan, P. K. (2019) · Subcellular Biochemistry · doi:10.1007/978-981-13-3681-2_6 · Cited by 308
Larsen, C., Østergaard, J., Larsen, S. W., Jensen, H., Jacobsen, S., Lindegaard, C., & Andersen, P. H. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21346 · Cited by 301
Update on the biology of the chondrocyte and new approaches to treating cartilage diseases
Goldring, M. B. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.06.003 · Cited by 298
Pharmacologic therapy for osteoarthritis—the era of disease modification
Hunter, D. J. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.178 · Cited by 288
CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene
Shen, S., Wu, Y., Chen, J., Xie, Z., Huang, K., Wang, G., Yang, Y., Ni, W., Chen, Z., Shi, P., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214786 · Cited by 279
“29 30 CircRNAs are endogenous noncoding RNAs that are widespread, tissue specific and conserved in mammalian cells and have a great potential that remains to be explored.”
Biological aspects of early osteoarthritis
Madry, H., Luyten, F. P., & Facchini, A. (2012) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-011-1705-8 · Cited by 265
Horie, M., Sekiya, I., Muneta, T., Ichinose, S., Matsumoto, K., Saito, H., Murakami, T., & Kobayashi, E. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0616 · Cited by 255
Recent advances in MMP inhibitor design
Fisher, J. F., & Mobashery, S. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7894-9 · Cited by 215
Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage
Davidson, R. K., Waters, J. G., Kevorkian, L., Darrah, C., Cooper, A., Donell, S. T., & Clark, I. M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2013 · Cited by 238
Bajpayee, A. G., Wong, C. R., Bawendi, M. G., Frank, E. H., & Grodzinsky, A. J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.091 · Cited by 223
Shi, Y., Hu, X., Cheng, J., Zhang, X., Zhao, F., Shi, W., Ren, B., Yu, H., Yang, P., Li, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09839-x · Cited by 221
Attur, M., Al-Mussawir, H. E., Patel, J., Kitay, A., Dave, M., Palmer, G., Pillinger, M. H., & Abramson, S. B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5082 · Cited by 216
Horie, M., Choi, H., Lee, R. H., Reger, R. L., Ylostalo, J., Muneta, T., Sekiya, I., & Prockop, D. J. (2012) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.06.002 · Cited by 202
Lascelles, B. D. X., Gaynor, J. S., Smith, E. S., Roe, S. C., Marcellin-Little, D. J., Davidson, G., Boland, E., & Carr, J. (2008) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2007.0014.x · Cited by 195
Biomimetic cartilage-lubricating polymers regenerate cartilage in rats with early osteoarthritis
Xie, R., Yao, H., Mao, A. S., Zhu, Y., Qi, D., Jia, Y., Gao, M., Chen, Y., Wang, L., Wang, D.-A., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00785-y · Cited by 188
Jeon, O. H., Wilson, D. R., Clement, C. C., Rathod, S., Cherry, C., Powell, B., Lee, Z., Khalil, A. M., Green, J. J., Campisi, J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125019 · Cited by 184
Karsdal, M. A., Madsen, S. H., Christiansen, C., Henriksen, K., Fosang, A. J., & Sondergaard, B. C. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2434 · Cited by 187
LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis
Zhang, Y., Wang, F., Chen, G., He, R., & Yang, L. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0302-2 · Cited by 171
Cell-Based Therapy Approaches: The Hope for Incurable Diseases
Buzhor, E., Leshansky, L., Blumenthal, J., Barash, H., Warshawsky, D., Mazor, Y., & Shtrichman, R. (2014) · Regenerative Medicine · doi:10.2217/rme.14.35 · Cited by 163
Lauder, R. M. (2009) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2008.08.004 · Cited by 159
Prospects for disease modification in osteoarthritis
Abramson, S. B., Attur, M., & Yazici, Y. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0193 · Cited by 162
Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit
Toghraie, F. S., Chenari, N., Gholipour, M. A., Faghih, Z. S., Torabinejad, S., Nazhvani, S. D., & Ghaderi, A. A. (2010) · The Knee · doi:10.1016/j.knee.2010.03.001 · Cited by 158
“OA is a chronic, degenerative process characterized by progressive cartilage deterioration, subchondral bone remodeling, loss of joint space, marginal osteophytosis, and loss of joint function [9–11].”
BackgroundZhao, Y., Wei, C., Chen, X., Liu, J., Yu, Q., Liu, J., & Liu, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b20372 · Cited by 153
Radical-Scavenging and Subchondral Bone-Regenerating Nanomedicine for Osteoarthritis Treatment
Lu, H., Wei, J., Liu, K., Li, Z., Xu, T., Yang, D., Gao, Q., Xiang, H., Li, G., & Chen, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c01789 · Cited by 150
Honoré, P., Chandran, P., Hernandez, G., Gauvin, D. M., Mikusa, J. P., Zhong, C., Joshi, S. K., Ghilardi, J. R., Sevcik, M. A., Fryer, R. M., et al. (2009) · Pain · doi:10.1016/j.pain.2008.11.004 · Cited by 147
Henrotin, Y., Marty, M., & Mobasheri, A. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.04.015 · Cited by 165
Phull, A. R., Majid, M., Haq, I., Khan, M. R., & Kim, S. J. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.01.051 · Cited by 149
Kaempferol: Paving the path for advanced treatments in aging-related diseases
Hussain, M. S., Altamimi, A. S. A., Afzal, M., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., Gupta, G., Shahwan, M. J., Kukreti, N., Wong, L. S., et al. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112389 · Cited by 155
McNamee, K., Burleigh, A., Gompels, L. L., Feldmann, M., Allen, S. J., Williams, R. O., Dawbarn, D., Vincent, T. L., & Inglis, J. J. (2010) · Pain · doi:10.1016/j.pain.2010.03.002 · Cited by 158
Fonseca‐Rodrigues, D., Rodrigues, A. L., Martins, T., Pinto, J. M., Amorim, D., Almeida, A., & Pinto‐Ribeiro, F. (2021) · Rheumatology · doi:10.1093/rheumatology/keab512 · Cited by 172
Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
Li, Z., Wang, Y., Ding, Y., Repp, L., Kwon, G. S., & Hu, Q. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100088 · Cited by 146
Vedadghavami, A., Wagner, E. K., Mehta, S., He, T., Zhang, C., & Bajpayee, A. G. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.004 · Cited by 136
“Osteoarthritis (OA) is a degenerative joint disease affecting millions of people, yet there is not a cure for it [1].”
BackgroundIgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis
Wang, Q., Lepus, C. M., Raghu, H., Reber, L. L., Tsai, M. M., Wong, H., von Kaeppler, E. P., Lingampalli, N., Bloom, M. S., Hu, N., et al. (2019) · eLife · doi:10.7554/elife.39905 · Cited by 145
“Current treatment approaches are limited to pain reduction and joint replacement, highlighting the importance of understanding the mechanisms underlying the pathogenesis (Chevalier et al., 2013; Wieland et al., 2005).”
BackgroundDave, M. N., Attur, M. G., Palmer, G. D., Al-Mussawir, H., Kennish, L., Patel, J., & Abramson, S. B. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23799 · Cited by 144
Corciulo, C., Lendhey, M., Wilder, T., Schoen, H., Cornelissen, A. S., Chang, G. A., Kennedy, O. D., & Cronstein, B. N. (2017) · Nature Communications · doi:10.1038/ncomms15019 · Cited by 139
Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers
Wang, I., Zhang, B., Yang, X., Zhu, J., Stepaniants, S., Zhang, C., Meng, Q., Peters, M. A., He, Y. D., Ni, C., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.24 · Cited by 135
Feline Degenerative Joint Disease
Lascelles, B. D. X. (2010) · Veterinary Surgery · doi:10.1111/j.1532-950x.2009.00597.x · Cited by 148
Hunter, D. J. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.11.008 · Cited by 174
Li, Y., Wang, Y., Chubinskaya, S., Schoeberl, B., Florine, E. M., Kopesky, P. W., & Grodzinsky, A. J. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.11.006 · Cited by 129
Cuervo, B., Rubio, M., Sopena, J. J., Domínguez, J. M., Vilar, J. M., Morales, M. F., Cugat, R., & Carrillo, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813437 · Cited by 124
Požgan, U., Caglič, D., Rozman, B., Nagase, H., Türk, V., & Turk, B. (2010) · Biological Chemistry · doi:10.1515/bc.2010.035 · Cited by 119
Kuah, D., Sivell, S., Longworth, T., James, K., Guermazi, A., Cicuttini, F., Wang, Y., Craig, S., Comin, G., Robinson, D., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1420-z · Cited by 127
Yan, Y., Lu, A., Dou, Y., Zhang, Z., Wang, X., Zhai, L., Ai, L., Du, M., Jiang, L., Zhu, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202207490 · Cited by 131
Review: The Role of MicroRNAs in Osteoarthritis and Chondrogenesis
Le, L. T. T., Swingler, T. E., & Clark, I. M. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37990 · Cited by 125
Inglis, J. J., McNamee, K., Chia, S., Essex, D. W., Feldmann, M., Williams, R. O., Hunt, S. P., & Vincent, T. L. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23870 · Cited by 115
Nguyen, P. D., Tran, T. D.-X., Nguyen, H. T.-N., Vu, H. T., Le, P. T.-B., Phan, N. L.-C., Vu, N. B., Phan, N. K., & Van Pham, P. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0023 · Cited by 112
Schaller, S., Henriksen, K., Høegh-Andersen, P., Søndergaard, B. C., Sumer, E. U., Tankó, L. B., Qvist, P., & Karsdal, M. A. (2005) · Assay and Drug Development Technologies · doi:10.1089/adt.2005.3.553 · Cited by 120
Articular cartilage tissue engineering: the role of signaling molecules
Kwon, H., Paschos, N. K., Hu, J. C. Y., & Athanasiou, K. A. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2115-8 · Cited by 117
Articular Cartilage: In Vivo Diffusion-Tensor Imaging
Raya, J. G., Horng, A., Dietrich, O., Krasnokutsky, S., Beltrán, L., Storey, P., Reiser, M. F., Recht, M. P., Sodickson, D. K., & Gläser, C. (2011) · Radiology · doi:10.1148/radiol.11110821 · Cited by 110
Graverand, M.-P. H. L. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.04.009 · Cited by 103
Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis
Qi, Y., Feng, G., & Yan, W. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1376-z · Cited by 105
Emerging drugs for osteoarthritis
Matthews, G., & Hunter, D. J. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.576670 · Cited by 114
Wang, D., Sima, M., Mosley, R. L., Davda, J. P., Tietze, N., Miller, S. C., Gwilt, P. R., Kopečková, P., & Kopec̆ek, J. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600539 · Cited by 94
Bui, K. H. T., Duong, T. D., Nguyen, N. T., Nguyen, T., Le, V. T., Mai, V. T., Phan, N. L. C., Le, D. M., Phan, N. K., & Pham, P. V. (2014) · Biomedical Research and Therapy · doi:10.7603/s40730-014-0002-9 · Cited by 98
Garay‐Mendoza, D., Martinez, L. V., Garza‐Bedolla, A., Pérez‐Garza, D. M., Acosta‐Olivo, C., Vílchez‐Cavazos, F., Diaz‐Hutchinson, C., Gómez‐Almaguer, D., Jaime‐Pérez, J. C., & Mancías‐Guerra, C. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13139 · Cited by 98
Wang, X., Fan, J., Ding, X., Sun, Y., Cui, Z., & Liu, W. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s216596 · Cited by 93
Dexamethasone: chondroprotective corticosteroid or catabolic killer?
Black, R. M., & Grodzinsky, A. J. (2019) · European Cells and Materials · doi:10.22203/ecm.v038a17 · Cited by 90
Synovial perlecan is required for osteophyte formation in knee osteoarthritis
Kaneko, H., Ishijima, M., Futami, I., Tomikawa-Ichikawa, N., Kosaki, K., SADATSUKI, R., Yamada, Y., Kurosawa, H., Kaneko, K., & Arikawa‐Hirasawa, E. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.01.004 · Cited by 98
Precise targeting of miR-141/200c cluster in chondrocytes attenuates osteoarthritis development
Ji, M.-L., Jiang, H., Wu, F., Geng, R., Ya, L. K., Lin, Y. C., Xu, J. H., Wu, X. T., & Lü, J. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218469 · Cited by 87
Bagi, C. M., Berryman, E. R., Teo, S. K., & Lane, N. E. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.08.013 · Cited by 84
Marini, I., Bartolucci, M. L., Bortolotti, F., Gatto, M. R., & Bonetti, G. A. (2012) · PubMed · Cited by 98
Culley, K. L., Wang, H., Barter, M. J., Davidson, R. K., Swingler, T. E., Destrument, A., Scott, J. L., Donell, S. T., Fenwick, S., Rowan, A. D., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37965 · Cited by 86
Li, H., Guo, H., Lei, C., Liu, L., Xu, L., Feng, Y., Ke, J., Fang, W., Song, H., Xu, C., et al. (2019) · Advanced Materials · doi:10.1002/adma.201904535 · Cited by 80
Therapeutic Potential of Differentiated Mesenchymal Stem Cells for Treatment of Osteoarthritis
Ham, O., Lee, C. Y., Kim, R., Lee, J., Oh, S., Lee, M., Kim, J., Hwang, K., Maeng, L.-S., & Chang, W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160714961 · Cited by 85
Quantitative Proteomic Profiling of Human Articular Cartilage Degradation in Osteoarthritis
Lourido, L., Calamia, V., Mateos, J., Fernández‐Puente, P., Fernandez-Tajes, J. J., Blanco, F. J., & Ruíz‐Romero, C. (2014) · Journal of Proteome Research · doi:10.1021/pr501024p · Cited by 87
Liao, Q., Li, B. J., Li, Y., Yu, X., Zeng, H., Liu, J. M., Li, Y., & Liu, G. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107824 · Cited by 82
Lubricants for osteoarthritis treatment: From natural to bioinspired and alternative strategies
Yuan, H., Mears, L. L. E., Wang, Y., Su, R., Qi, W. D., He, Z., & Valtiner, M. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102814 · Cited by 78
Block, J. E., Stiebel, M., & Miller, L. E. (2014) · Open Access Journal of Sports Medicine · doi:10.2147/oajsm.s61865 · Cited by 90
Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm
Aziz, F., & Kuivaniemi, H. (2007) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2006.11.001 · Cited by 78
Platelet-Rich Plasma Modulates Actions on Articular Cartilage Lubrication and Regeneration
Sakata, R., & Reddi, A. H. (2016) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2015.0534 · Cited by 77
An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis
Ryan, S. M., McMorrow, J. P., Umerska, A. M., Patel, H., Kornerup, K. N., Tajber, L., Murphy, E. P., Perretti, M., Corrigan, O. I., & Brayden, D. J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.027 · Cited by 79
Vitamin D, race, and experimental pain sensitivity in older adults with knee osteoarthritis
Glover, T. L., Goodin, B. R., Horgas, A. L., Kindler, L. L., King, C. D., Sibille, K. T., Peloquin, C. A., Riley, J. L., Staud, R. M., Bradley, L. A., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37687 · Cited by 82
Williams, T. G., Holmes, A. P., Waterton, J. C., Maciewicz, R. A., Hutchinson, C. E., Moots, R. J., Nash, A., & Taylor, C. (2010) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2010.2047653 · Cited by 85
Recent Advances in Understanding the Role of Cartilage Lubrication in Osteoarthritis
Li, Y., Yuan, Z., Yang, H. L., Zhong, H., Peng, W., & Xie, R. (2021) · Molecules · doi:10.3390/molecules26206122 · Cited by 84
Wojdasiewicz, P., Poniatowski, Ł. A., Kotela, A., Deszczyński, J., Kotela, I., & Szukiewicz, D. (2014) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-014-0275-0 · Cited by 90
Howard, M. A., Sanders, D., Krause, K., O’Muircheartaigh, J., Fotopoulou, A., Zelaya, F. O., Thacker, M. A., Massat, N. J., Huggins, J. P., Vennart, W., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37685 · Cited by 89
Wei, T., Kulkarni, N. H., Zeng, Q., Helvering, L. M., Lin, X., Lawrence, F., Hale, L. V., Chambers, M. G., Lin, C., Harvey, A., et al. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.04.012 · Cited by 73
Bani, S., Gautam, M., Sheikh, F. A., Khan, B., Satti, N. K., Suri, K. A., Qazi, G. N., & Patwardhan, B. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.02.016 · Cited by 73
“However, their clinical efficacy as been limited and has associated complications (Oberholzer t al., 2000; Wieland et al., 2005).”
BackgroundConnor, J. R., LePage, C., Swift, B. A., Yamashita, D. S., Bendele, A. M., Maul, D., & Kumar, S. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.03.015 · Cited by 73
Gege, C., Bao, B., Bluhm, H., Boer, J., Gallagher, B. M., Korniski, B., Powers, T. S., Steeneck, C., Taveras, A. G., & Baragi, V. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201152u · Cited by 73
Ziadlou, R., Barbero, A., Martín, I., Wang, X., Qin, L., Alini, M., & Grad, S. (2020) · Biomolecules · doi:10.3390/biom10060932 · Cited by 75
“RNA sequencing and gene expression data revealed that besides COL2A1 and ACAN also other anabolic genes including GDF-5, COMP, and CCN2 were significantly upregulated in the treatment group with Epi C (Figure 1).”
BackgroundInfluentialDegradome expression profiling in human articular cartilage
Swingler, T. E., Waters, J. G., Davidson, R. K., Pennington, C. J., Puente, X. S., Darrah, C., Cooper, A., Donell, S. T., Guile, G. R., Wang, W., et al. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2741 · Cited by 74
Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches
Rainbow, R. S., Ren, W., & Zeng, L. (2012) · Arthritis · doi:10.1155/2012/741582 · Cited by 85
Tyrosine kinase Fyn promotes osteoarthritis by activating the β-catenin pathway
Li, K., Zhang, Y., Zhang, Y., Jiang, W., Shen, J., Xu, S., Cai, D., Shen, J., Huang, B., Li, M., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212658 · Cited by 80
Chang, J. C., Sebastian, A., Murugesh, D. K., Hatsell, S. J., Economides, A. N., Christiansen, B., & Loots, G. G. (2016) · Journal of Orthopaedic Research® · doi:10.1002/jor.23263 · Cited by 78
Hochberg, M. C., Chevalier, X., Henrotin, Y. E., Hunter, D. J., & Uebelhart, D. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.753430 · Cited by 78
Kanzaki, N., Saito, K., Maeda, A., Kitagawa, Y., Kiso, Y., Watanabe, K., Tomonaga, A., Nagaoka, I., & Yamaguchi, H. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4660 · Cited by 71
Metadata
- Authors
- Wieland, H. A., Michaelis, M., Kirschbaum, B. J., & Rudolphi, K. A.
- Affiliations
- Sanofi (Germany) (DE)
- Corresponding author
- Wieland, Heike A.
- ORCID
- Michaelis, Martin
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-04
- Volume
- 4
- Issue
- 4
- Pages
- 331-344
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1487036716
- Cited by
- 585
- References
- 124
- Citations by year
- 2026: 34 · 2025: 32 · 2024: 44 · 2023: 31 · 2022: 36 · 2021: 34 · 2020: 25 · 2019: 36 · 2018: 24 · 2017: 31 · 2016: 26 · 2015: 29 · 2014: 29 · 2013: 32 · 2012: 29
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacological Effects of Medicinal Plants
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- osteoarthritis, disease-modifying therapy, early-onset osteoarthritis, pharmacotherapy, treatment options
- MeSH terms
- Anti-Inflammatory Agents, Non-Steroidal, Humans, Osteoarthritis, Pain, Drug Design, Molecular Structure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.